• Explore /
  • Poster
  • / Phase II study of pembrolizumab plus capecitabine and bevacizumab in microsatellite stable (MSS) metastatic colorectal cancer (mCRC): Interim analysis.

Phase II study of pembrolizumab plus capecitabine and bevacizumab in microsatellite stable (MSS) metastatic colorectal cancer (mCRC): Interim analysis.

Abstract Video & Slides Poster

Authors

null

Andrea Grace Bocobo

University of California San Francisco, Helen Diller Family Comprehensive Cancer Center, San Francisco, CA

Andrea Grace Bocobo , Renee Wang , Spencer Behr , Julia C. Carnevale , Pelin Cinar , Eric Andrew Collisson , Lawrence Fong , Wesley Allen Kidder , Andrew H. Ko , Kanti Pallav Kolli , Megan Kennedy , Angela Laffan , Sheila Lindsay , Sneha Nalla , Gabriel Schwartz , Julia Whitman , Patricia Zendejas , Li Zhang , Katherine Van Loon , Chloe Evelyn Atreya

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session: Colorectal Cancer

Track

Colorectal Cancer

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT03396926

Citation

J Clin Oncol 39, 2021 (suppl 3; abstr 77)

DOI

10.1200/JCO.2021.39.3_suppl.77

Abstract #

77

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Andrea Grace Bocobo

First Author: Tyler Friedrich

First Author: Christopher Hanyoung Lieu

Poster

2017 Gastrointestinal Cancers Symposium

A phase I/II study of nintedanib and capecitabine in refractory metastatic colorectal cancer.

A phase I/II study of nintedanib and capecitabine in refractory metastatic colorectal cancer.

First Author: Patrick McKay Boland